|
인쇄하기
취소
|
Yungjin to launch generic Actos
Published: 2008-07-21 06:55:00
Updated: 2008-07-21 06:55:00
Yungjin Pharm says it will launch the first generic version of Actos (pioglitazone hydrochloride), Glitzone 15 mg (823 won per tablet) from August 1.
Actos is a medication that is commonly prescribed to treat type 2 diabetes in adults. It is a form of thiazolidinedione, which works to lower and control blood sugar by improving insulin sensitivity. The medicine comes as a tablet that is taken...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.